In the dynamic landscape of the medical services industry, Teladoc Health (NYSE: TDOC) stands as one of many publicly-traded entities vying for investor attention. A comprehensive comparison against its rivals reveals crucial insights into its market position, offering a detailed perspective for potential stakeholders navigating healthcare investment opportunities.
A significant indicator of investor confidence lies in institutional ownership, where Teladoc Health boasts 76.8% of its shares held by large money managers, hedge funds, and endowments. This figure notably surpasses the 58.1% average for the broader medical services sector, suggesting a strong belief among major players that TDOC possesses long-term outperforming potential in the stock market.
Conversely, insider ownership for Teladoc Health is minimal at 0.6%, starkly lower than the industry average of 13.1%. While high institutional ownership often signals professional backing, the lower insider stake might prompt further scrutiny into the alignment of company leadership with shareholder interests when evaluating overall stock market performance and company health.
Analyst consensus paints a mixed picture regarding Teladoc Health’s growth prospects. The company currently holds a consensus price target of $9.76, indicating a potential upside of 40.69%. However, when juxtaposed against its rivals, the average “Medical Services” company projects a much higher potential upside of 447.08%, suggesting analysts perceive less aggressive growth trajectories for TDOC.
Volatility, measured by beta, reveals Teladoc Health’s stock to be significantly more reactive to market fluctuations. With a beta of 1.76, TDOC is 76% more volatile than the S&P 500. This is higher than its rivals’ average beta of 1.64, highlighting a comparatively greater risk profile for Teladoc Health investments in a fluctuating stock market environment.
Financially, Teladoc Health’s rivals generally report higher revenue and earnings figures. Despite this, Teladoc Health trades at a more attractive price-to-earnings (P/E) ratio than its competitors, signaling it might be currently undervalued or offers a more affordable entry point for investors considering its specific niche within the medical services industry.
Teladoc Health, Inc. provides virtual healthcare services globally, operating through two primary segments: Teladoc Health Integrated Care and BetterHelp. The Integrated Care segment delivers a wide range of virtual medical services, including general, expert, and specialty medical care, chronic condition management, and mental health support. The BetterHelp segment focuses specifically on online counseling and therapy via various digital platforms.
Established in 2002 as Teladoc, Inc. and rebranded in August 2018, the company serves a diverse client base including employers, health plans, hospitals, and individual members. Headquartered in Purchase, New York, Teladoc Health continues to innovate in the telehealth sector, striving to expand its reach and improve access to comprehensive virtual care services for a growing global market.
